LB PHARMACEUTICALS INC

Profile

Company Names

LB PHARMACEUTICALS INC
LB PHARMACEUTICALS INC.

Addresses

575 MADISON AVENUE, NEW YORK, NY 10022

575 MADISON AVENUE, 10TH FLOOR, NEW YORK, NY 10022

Phone Numbers

917-450-6581

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$141,367,884.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2023-08-29 
$110,730,354.00 
$110,730,354.00 
$0.00 
Equity 
8
2022-10-21 
$16,574,000.00 
$40,000,000.00 
$23,426,000.00 
Debt 
7
2022-05-03 
$903,350.00 
INDEFINITE 
INDEFINITE 
Equity 
6
2020-08-18 
$4,629,200.00 
$10,000,000.00 
$5,370,800.00 
Debt 
5
2018-11-21 
$6,326,835.00 
$10,000,000.00 
$3,673,165.00 
Equity 
4
2018-05-03 
$330,000.00 
$750,000.00 
$420,000.00 
Equity, Debt 
3
2017-12-20 
$443,200.00 
$443,200.00 
$0.00 
Equity 
2
2017-04-05 
$462,000.00 
$462,000.00 
$0.00 
Equity 
1
2016-11-25 
$968,945.00 
$1,000,000.00 
$31,055.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANNA 
 
ERAMO 
EXECUTIVE OFFICER
VINCENT 
 
GRATTAN 
DIRECTOR
REBECCA 
 
LUSE 
DIRECTOR
MARC 
 
PANOFF 
EXECUTIVE OFFICER
MARK 
 
PANOFF 
EXECUTIVE OFFICER
PIERO 
 
POLI 
DIRECTOR
ZACHARY 
 
PRENSKY 
EXECUTIVE OFFICER, DIRECTOR
LAUREN 
 
STIPP 
EXECUTIVE OFFICER
EDMUND 
 
SULLIVAN 
DIRECTOR
ANDREW 
 
VAINO 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-29 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-29 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-08-18 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-20 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-05-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-05 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MAXIM GROUP LLC
AGILE CAPITAL MARKETS
NONE
AGILE CAPITAL MARKETS
NONE
NA
NONE
MAXIM GROUP LLC
MAXIM GROUP LLC
MAXIM GROUP LLC